Topics:
Acute Coronary Syndromes (ACS)
Current versions available to download
Current translated versions available to download:
Authors
S. Silber FESC (Chairperson), P. Albertsson, F. Fernandez-Avilès FESC, P. G. Camici FESC, A. Colombo FESC, C. Hamm FESC, E. Jorgensen FESC, J. Marco FESC, J-E. Nordrehaug FESC, W. Ruzyllo FESC, P. Urban, G. W. Stone, W. Wijns FESC
Endorsed by:
Table of contents: Full Text (ESC Clinical Practice Guidelines)
|
|
|
Introduction and definitions
|
- Method of review
- Definition of levels of recommendation
|
Indications for PCI
|
- Indications for PCI in stable coronary artery disease
- Indications for PCI in acute coronary syndromes without ST-segment elevation
- Indications for PCI in ACS with ST-segment elevation
|
Adjunctive medications for PCI
|
- Acetylsalicylic acid
- Ticlopidine and clopidogrel
- Unfractionated heparin
- Low molecular weight heparins
- Glycoprotein IIb/IIIa inhibitors
- Direct thrombin inhibitors
|
Adjunctive devices for PCI
|
- Intracoronary brachytherapy for in-stent restenosis
- Cutting balloon
- Rotablation
- Directional coronary atherectomy
- Embolic protection devices
- Adjunctive diagnostic technology
|
Drug-eluting stents
|
- Vessel size, long lesions, diabetes,
- Stent thrombosis of DES
- Indications for DES
|
Previous versions
A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here